Camber debuts generic Banzel
Rufinamide Oral Suspension is indicated for adjunctive treatment of seizures associated with Lennox-Gastaut Syndrome in pediatric patients aged 1 year old and older, and in adults.
Camber is introducing Rufinamide Oral Suspension, which is the generic of Banzel.
Rufinamide Oral Suspension is indicated for adjunctive treatment of seizures associated with Lennox-Gastaut Syndrome in pediatric patients aged 1 year old and older, and in adults.
[Read more: Camber launches generic Phenergan]
Rufinamide Oral Suspension 40 mg/ml is available in a 460 ml bottle with child-resistant closure along with two calibrated oral dosing syringes and an adapter.